Literature DB >> 30178828

MiR-203 is involved in osteoporosis by regulating DKK1 and inhibiting osteogenic differentiation of MSCs.

Z-L Xia1, Y Wang, Q-D Sun, X-F Du.   

Abstract

OBJECTIVE: To investigate whether miR-203 is involved in the osteogenic differentiation of rat mesenchymal stem cells (MSCs) by regulating DDK1, thus participating in the pathogenesis of osteoporosis. PATIENTS AND METHODS: miR-203 expression in serum samples of 60 osteoporosis patients and 60 normal subjects was detected using Real-time fluorescence quantitative polymerase chain reaction (qRT-PCR) assay. MSCs were isolated from bone marrow of rats and then identified. Subsequently, the effects of miR-203 and DKK1 on osteogenic differentiation were estimated by alkaline phosphatase (ALP) activity, alizarin red staining, ALP staining, respectively. Expression levels of osteogenic-specific genes were detected by Western blot. Rescue experiments were conducted to confirm whether miR-203 could promote osteogenic differentiation of MSCs by inhibiting DKK1.
RESULTS: Serum level of miR-203 in osteoporosis patients was significantly lower than that of the normal subjects. Overexpressed miR-203 in MSCs enhanced ALP activity, expression of osteogenic marker genes and the number of calcified cells. Additionally, miR-203 could bind to DKK1. The regulatory effect of miR-203 on osteogenic differentiation in MSCs was reversed by DKK1.
CONCLUSIONS: MiR-203 promotes the differentiation of rat MSCs into osteoblast-like cells, which may be associated with the regulation of DKK1 expression.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30178828     DOI: 10.26355/eurrev_201808_15703

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  7 in total

1.  Downregulation of LINC00707 promotes osteogenic differentiation of human bone marrow‑derived mesenchymal stem cells by regulating DKK1 via targeting miR‑103a‑3p.

Authors:  Jun Liu; Minfei Wu; Guang Feng; Rui Li; Yang Wang; Jianhang Jiao
Journal:  Int J Mol Med       Date:  2020-07-09       Impact factor: 4.101

Review 2.  Perspectives on miRNAs Targeting DKK1 for Developing Hair Regeneration Therapy.

Authors:  Dimitri Papukashvili; Nino Rcheulishvili; Cong Liu; Fengfei Xie; Deependra Tyagi; Yunjiao He; Peng George Wang
Journal:  Cells       Date:  2021-10-30       Impact factor: 6.600

3.  miR-23b mediates TNF-α-Inhibited Osteogenic Differentiation of Human Periodontal Ligament Stem Cells by Targeting Runx2.

Authors:  Xuefei Sun; Mingwei Li; Jinghao Ban; Zhidan Li
Journal:  Int J Med Sci       Date:  2021-09-09       Impact factor: 3.738

Review 4.  Drug Discovery of DKK1 Inhibitors.

Authors:  Hewen Jiang; Zongkang Zhang; Yuanyuan Yu; Hang Yin Chu; Sifan Yu; Shanshan Yao; Ge Zhang; Bao-Ting Zhang
Journal:  Front Pharmacol       Date:  2022-03-09       Impact factor: 5.810

Review 5.  The Role of MicroRNAs in Bone Metabolism and Disease.

Authors:  Yongguang Gao; Suryaji Patil; Airong Qian
Journal:  Int J Mol Sci       Date:  2020-08-24       Impact factor: 5.923

Review 6.  Circulating MicroRNAs as Novel Biomarkers for Osteoporosis and Fragility Fracture Risk: Is There a Use in Assessment Risk?

Authors:  Simone Ciuffi; Simone Donati; Francesca Marini; Gaia Palmini; Ettore Luzi; Maria Luisa Brandi
Journal:  Int J Mol Sci       Date:  2020-09-21       Impact factor: 5.923

Review 7.  Application of microRNA in Human Osteoporosis and Fragility Fracture: A Systemic Review of Literatures.

Authors:  Yen-Zung Wu; Hsuan-Ti Huang; Tsung-Lin Cheng; Yen-Mou Lu; Sung-Yen Lin; Cheng-Jung Ho; Tien-Ching Lee; Chia-Hao Hsu; Peng-Ju Huang; Han Hsiang Huang; Jhong-You Li; Yu-De Su; Shih-Chieh Chen; Lin Kang; Chung-Hwan Chen
Journal:  Int J Mol Sci       Date:  2021-05-15       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.